Strs Ohio Has $85.26 Million Stock Position in McKesson Corporation $MCK

Key Points

• Strs Ohio trimmed its McKesson stake by 9.7% in Q4, selling 11,145 shares and finishing the period with 103,940 shares valued at $85.26 million, about 0.08% of the company.
• Analysts remain largely positive — 14 Buys vs. 3 Holds give a consensus rating of “Moderate Buy” with an average price target of $972.27, and JPMorgan recently raised its target to $1,107.
• McKesson topped Q4 estimates with $9.34 EPS on $106.16B revenue, set FY2026 guidance at 38.80–39.20 EPS, and pays a quarterly dividend of $0.82 (annualized $3.28, ~0.4% yield).

Strs Ohio reduced its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 9.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 103,940 shares of the company's stock after selling 11,145 shares during the quarter. Strs Ohio owned 0.08% of McKesson worth $85,261,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in MCK. Brighton Jones LLC grew its holdings in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock valued at $1,438,000 after buying an additional 798 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of McKesson during the first quarter valued at about $233,000. Sivia Capital Partners LLC grew its holdings in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock valued at $502,000 after buying an additional 300 shares during the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of McKesson by 0.9% during the second quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company's stock valued at $42,958,000 after buying an additional 508 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new position in shares of McKesson during the second quarter valued at about $166,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Robert W. Baird set a $968.00 price objective on shares of McKesson in a report on Wednesday, January 14th. JPMorgan Chase & Co. boosted their price target on shares of McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a report on Tuesday, February 10th. Raymond James Financial set a $970.00 price target on shares of McKesson in a report on Thursday, March 5th. William Blair assumed coverage on shares of McKesson in a report on Tuesday. They set an "outperform" rating on the stock. Finally, Weiss Ratings cut shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $972.27.

McKesson Stock Down 0.1%

NYSE MCK opened at $814.69 on Friday. The company's 50 day moving average is $894.86 and its 200-day moving average is $859.16. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The firm has a market cap of $99.79 billion, a P/E ratio of 23.43, a price-to-earnings-growth ratio of 1.18 and a beta of 0.35.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson's revenue was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts expect that McKesson Corporation will post 39.02 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson's dividend payout ratio (DPR) is currently 9.43%.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 190 shares of the company's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president directly owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Maria Martinez sold 349 shares of the stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director owned 301 shares of the company's stock, valued at approximately $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 3,592 shares of company stock worth $3,518,555 in the last quarter. 0.08% of the stock is currently owned by company insiders.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.